Swiss startup FluoSphera secures CHF 1.15M seed funding to scale 3D human organ models designed to predict drug toxicity earlier and cut costly clinical trial failures.
Browsing: Science
Habitasse platea dictumst vestibulum rhoncus est pellentesque elit. Enim diam vulputate ut pharetra sit amet aliquam id.
French MedTech FineHeart raises €83M in private capital and EU grants to accelerate its implantable cardiac device for patients with advanced heart failure.
Femtech startup BrightHeart has raised €11M to develop AI-driven tools that aim to make prenatal screening more accurate, accessible, and affordable worldwide.
French biotech startup Spore.Bio secures multi‑million‑euro support from Google.org and launches an AI‑native research unit to accelerate safer, smarter biological innovation in Europe.
London-based Engitix secures a €21M funding extension to accelerate its extracellular matrix–targeted therapies for cancer and fibrosis, strengthening its position in drug discovery.
Norwegian incubator OSE scores a second major biotech exit as Amgen acquires oncology startup Dark Blue in a deal worth up to $840M.
Icelandic biotech Alvotech ramps up biosimilars development and manufacturing capacity to meet surging global demand for affordable biologic medicines.
Clean energy could require five times more critical metals by 2040. New mining, recycling, and processing technologies may prevent shortages and price shocks.
Planet A says space infrastructure is the century’s most underpriced opportunity, pointing to launch, satellites, and in-orbit services as the next backbone for the global economy.
German BioTech startup BIOWEG has raised €1.5 million to turn industrial waste streams into valuable metals, targeting cleaner recovery methods and circular manufacturing.